<DOC>
	<DOCNO>NCT00256555</DOCNO>
	<brief_summary>Cystic fibrosis ( CF ) catabolic condition , child affect disease frequently problem growth , despite adequate nutrition . We hypothesize anabolic effect growth hormone ( GH ) improve height weight CF patient thereby improve clinical status quality life . We hypothesize effect sustain least one year GH treatment complete .</brief_summary>
	<brief_title>Growth Hormone Treatment Study Children With Cystic Fibrosis</brief_title>
	<detailed_description>We test hypothesis recruit 40 CF child five CF center ( 8 per center ) across country . Patients randomly assign receive treatment GH ( 0.3 mg/kg/wk ) first 12 month , second 12 month . All subject follow every three month entire 24 month . Growth data PFT data year prior study obtain medical record subject . Our specific aim include : 1 . To determine effect GH height , height velocity , body weight lean body mass . We measure height weight use standardized stadiometer scale , respectively , every three month study . From measurement calculate height weight velocity height weight Z score . Lean body mass ( LBM ) measure DEXA every six month . Baseline height weight analyze covariates determine whether child whose height and/or weight low percentile achieve great improvement height weight velocity lean body mass . This specific aim test hypothesis GH significantly improve height , height velocity , weight , weight velocity lean body mass CF child irrespective growth prior start drug . 2 . To determine effect GH pulmonary function . Pulmonary function test , include FEV1 , FVC PImax PEmax ( estimation respiratory muscle strength ) , measure baseline every 6 month subject . We document inpatient admission outpatient antibiotic therapy study . Baseline pulmonary function analyze covariate determine whether child good pulmonary function achieve great benefit child poor pulmonary function . This specific aim test hypothesis GH use improve pulmonary function CF child regardless level pulmonary function prior use drug . 3 . To determine GH use CF patient positively impact quality life . At baseline every six month , administer 15 minute questionnaire parent patient ass quality life . These questionnaire entitle `` The Cystic Fibrosis Questionnaire '' recently develop tested quality . They specific CF patient approve National CF Foundation . This specific aim test hypothesis GH use improve quality life CF patient . 4 . To determine clinical improvement obtain GH use sustain . Those patient treat GH first 12 month follow 12 month treatment determine outcome variable remain good baseline growth hormone therapy discontinue . This specific aim test hypothesis GH use result sustain improvement height velocity , weight velocity , lean body mass , pulmonary function quality life .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>prepubertal CF patient ( age 512 ) capable perform pulmonary function test less 25th percentile age sex normal value height and/or weight . previous diagnosis diabetes previous insulin requirement inability perform pulmonary function test colonization burkholderia cepacia</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>November 2005</verification_date>
</DOC>